Structured evidence table for Glucosamine Cartilage Health Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Glucosamine Cartilage Health Meta-Analysis | To ensure a robust synthesis of evidence, we conducted a systematic search of PubMed, Embase, and Web of Science (2020-2025) for high-quality clinical trials, meta-analyses, and guidelines. | 4 | Wang H (2026) | Evolving Strategies for Knee Osteoarthritis: A Narrative Review of Integrated Rehabilitation, Pharmacologic, and Joint-Preserving Interventions. |
| Glucosamine Cartilage Health Meta-Analysis | This narrative review evaluates the clinical transition from reactive, surgery-centric models to a proactive, integrated framework to mitigate the profound socioeconomic burden and functional decline associated with the disease. | 4 | Wang H (2026) | Evolving Strategies for Knee Osteoarthritis: A Narrative Review of Integrated Rehabilitation, Pharmacologic, and Joint-Preserving Interventions. |
| Glucosamine Cartilage Health Meta-Analysis | We synthesized evidence across non-pharmacological rehabilitation, pharmacotherapy, and advanced joint-preserving surgeries, emphasizing optimal intervention windows and stage-specific mechanobiological requirements. | 4 | Wang H (2026) | Evolving Strategies for Knee Osteoarthritis: A Narrative Review of Integrated Rehabilitation, Pharmacologic, and Joint-Preserving Interventions. |
| Glucosamine Cartilage Health Meta-Analysis | Knee osteoarthritis (KOA) is a primary driver of global disability, currently affecting over 365 million adults, with projections suggesting a 74.9% increase by 2050. | 4 | Wang H (2026) | Evolving Strategies for Knee Osteoarthritis: A Narrative Review of Integrated Rehabilitation, Pharmacologic, and Joint-Preserving Interventions. |
| Glucosamine Cartilage Health Meta-Analysis | Osteoarthritis (OA) is prevalent in the Indian subcontinent and Southeast Asia, causing pain, reduced mobility, and disability. | 4 | Prabhoo R (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion. |
| Glucosamine Cartilage Health Meta-Analysis | An evidence-based analysis showed that undenatured type II collagen (40 mg/day) improves pain, stiffness, function, and quality of life in early-to-moderate OA (Grades 1-3), with benefits observed within eight weeks, improved compliance, and non-steroidal anti-inflammatory drug-sparing effects. | 4 | Prabhoo R (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion. |
| Glucosamine Cartilage Health Meta-Analysis | Comparative evidence favors UC-II® (Lonza Greenwood LLC, USA) over other sources, highlighting the importance of product selection. | 4 | Prabhoo R (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion. |
| Glucosamine Cartilage Health Meta-Analysis | Genetic, lifestyle, and comorbidity factors contribute to earlier onset and more severe disease than in Western populations. | 4 | Prabhoo R (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion. |
Source documents